Recursion Pharmaceuticals Inc
RXRX
$4.03+8.92%
End of day · as of Sep 29, 2026, 6:45 PM ET
Mkt cap
$1.75B
EV/Sales
13.6
P/E ratio
N/A
FY2025 Revenue
$74.68M
EPS (TTM)
$-1.00
Gross Margin (FY2025)
4.99%
Profit Margin (FY2025)
-863.35%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported RXRX revenue for 2025-12-31 was $74.7M. Net income was -$644.8M. Revenue was up 26.9% from 2024-12-31 to 2025-12-31. RXRX currently screens at market cap $1.75B.
Use this RXRX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RXRX income, balance, and cash tables.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company in the Healthcare sector.
Latest cached Recursion Pharmaceuticals Inc (RXRX) revenue for Dec 31, 2025 was $74.7M. Net income was -$644.8M. Statements: https://lician.com/financials/rxrx
Recursion Pharmaceuticals Inc (RXRX) market capitalization is $1.75B on the latest cached snapshot.
Recursion Pharmaceuticals Inc (RXRX) cached previous close $3.70; day range $3.72 – $4.04; volume 21,358,887. Session quote: https://lician.com/quote/rxrx
Recursion Pharmaceuticals Inc (RXRX) latest cached earnings event is "RXRX earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached RXRX filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/rxrx